Third Wave, Chiron, Bayer Dismiss HCV Patent Suit (Hep C Treatment)

Third Wave, Chiron, Bayer Dismiss HCV Patent Suit
[Press Release] PR Newswire via Yahoo! Finance - Feb 23 5:00 AM
Third Wave Technologies Inc. today announced that it has reached an agreement with Chiron Corp., Bayer Corp., and Bayer HealthCare, LLC under which the companies jointly will seek the dismissal without prejudice of Third Wave's lawsuit against Chiron and Bayer over patents related to hepatitis C virus, or HCV.Save to My Web

Popular Science Magazine Features The Aethlon Hemopurifier(TM)
[Press Release] Business Wire via Yahoo! Finance - Mar 14 4:00 AM
SAN DIEGO----March 14, 2006--Aethlon Medical, Inc. , a pioneer in developing therapeutic devices for infectious disease, announced today that its Hemopurifier treatment technology is featured in the April issue of Popular Science Magazine.Save to My Web

InterMune to Present at the Bear Biotech West Coast Confab
[Press Release] PR Newswire via Yahoo! Finance - Mar 16 2:08 PM
InterMune, Inc. announced today that it will present a corporate overview at the Bear Biotech West Coast Confab in San Francisco, CA on Thursday, March 23, 2006 at 2:00 p.m. PST.Save to My Web